Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherene Loi

Showing results (91-100 of 325) with videos related to

Pageof 33
Sort By:
Histopathology|November 22, 2023
Spatial transcriptomics and the anatomical pathologist: Molecular meets morphologyJia-Min B Pang, David J Byrne, Alice R T Bergin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Obesity and outcomes in premenopausal and postmenopausal breast cancerSherene Loi, Roger L Milne, Michael L Friedlander, et al.
Oncoimmunology|October 10, 2015
CD73: A potential biomarker for anti-PD-1 therapyPaul A Beavis, Clare Y Slaney, Nicole Milenkovski, et al.
Cell|April 14, 2023
The next big questions in cancer researchSherene Loi, Jeffrey Settleman, Johanna A Joyce, et al.
Breast Cancer Research and Treatment|November 23, 2018
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysisKirsty Wai Chung Lee, Sally Lord, Richard S Finn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysisMichail Ignatiadis, Sandeep K Singhal, Christine Desmedt, et al.
Breast Cancer Research : BCR|April 8, 2015
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancyHatem A Azim, Fedro A Peccatori, Sylvain Brohée, et al.
Cancer Treatment Reviews|May 7, 2013
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancerKamal S Saini, Sherene Loi, Evandro de Azambuja, et al.
Cancer Immunology Research|February 13, 2015
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell ResponsesPaul A Beavis, Nicole Milenkovski, Melissa A Henderson, et al.
Nature Reviews. Cancer|July 5, 2024
Towards targeting the breast cancer immune microenvironmentMichael A Harris, Peter Savas, Balaji Virassamy, et al.
Pageof 33

Showing results (91-100 of 325) with videos related to

Sort By:
Pageof 33
Histopathology|November 22, 2023
Spatial transcriptomics and the anatomical pathologist: Molecular meets morphologyJia-Min B Pang, David J Byrne, Alice R T Bergin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Obesity and outcomes in premenopausal and postmenopausal breast cancerSherene Loi, Roger L Milne, Michael L Friedlander, et al.
Oncoimmunology|October 10, 2015
CD73: A potential biomarker for anti-PD-1 therapyPaul A Beavis, Clare Y Slaney, Nicole Milenkovski, et al.
Cell|April 14, 2023
The next big questions in cancer researchSherene Loi, Jeffrey Settleman, Johanna A Joyce, et al.
Breast Cancer Research and Treatment|November 23, 2018
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysisKirsty Wai Chung Lee, Sally Lord, Richard S Finn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysisMichail Ignatiadis, Sandeep K Singhal, Christine Desmedt, et al.
Breast Cancer Research : BCR|April 8, 2015
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancyHatem A Azim, Fedro A Peccatori, Sylvain Brohée, et al.
Cancer Treatment Reviews|May 7, 2013
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancerKamal S Saini, Sherene Loi, Evandro de Azambuja, et al.
Cancer Immunology Research|February 13, 2015
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell ResponsesPaul A Beavis, Nicole Milenkovski, Melissa A Henderson, et al.
Nature Reviews. Cancer|July 5, 2024
Towards targeting the breast cancer immune microenvironmentMichael A Harris, Peter Savas, Balaji Virassamy, et al.
Pageof 33